Dijkstra M, Kraus J S, Bosje J T, Den Hertog E
Medisch Centrum voor Dieren, afdeling interne genees-kunde, Weesperzijde 147, 1091 ET Amsterdam.
Tijdschr Diergeneeskd. 2010 May 15;135(10):406-12.
To describe the signs, histopathological features, and treatment outcome of a not previously described protein-losing enteropathy (PLE) in Rottweiler dogs.
A retrospective study involving 17 Rottweilers referred for PLE. Data on sex, age, presenting signs, histopathological diagnosis, and treatment outcome were collected. The canine inflammatory bowel disease activity index (CIBDAI) score was calculated, to quantify disease severity. Endoscopic intestinal biopsies were evaluated according to the guidelines of the World Small Animal Veterinary Association (WSAVA) gastrointestinal standardization group.
Presenting signs were watery diarrhoea and weight loss. In all dogs with PLE in this study, the abnormalities found were consistent with a form of inflammatory bowel disease. Some of the dogs had a secondary infection with Giardia or Cyniclomyces guttulatus. In 10 dogs (59%) the CIBDAI score was 9 or higher, indicative of severe disease. Histopathological findings revealed lymphoplasmacellular enteritis, with lymphangiectasia in 14 (82%) dogs and eosinophil infiltration in 10 (59%) dogs. Eleven (65%) dogs were euthanized or died because of the intestinal disease. Kaplan-Meier analysis revealed a median survival time of 5 months, with a 1-year survival rate of 47%. Seven (4%) dogs were disease-free after treatment with immunosuppressants and dietary measures, but some relapsed (median disease-free interval 21 months).
In Rottweilers presenting with chronic diarrhoea and weight loss, clinicians should consider the presence of severe PLE, which has a poor prognosis.
描述一种此前未被描述的罗威纳犬蛋白丢失性肠病(PLE)的体征、组织病理学特征及治疗结果。
一项回顾性研究,纳入17只因PLE转诊的罗威纳犬。收集有关性别、年龄、临床表现、组织病理学诊断及治疗结果的数据。计算犬炎症性肠病活动指数(CIBDAI)评分以量化疾病严重程度。根据世界小动物兽医协会(WSAVA)胃肠标准化小组的指南对内镜下肠道活检进行评估。
临床表现为水样腹泻和体重减轻。在本研究中所有患有PLE的犬只中,发现的异常均与一种炎症性肠病形式相符。部分犬继发贾第虫或斑点杯霉感染。10只犬(59%)的CIBDAI评分为9或更高,表明疾病严重。组织病理学结果显示淋巴细胞浆细胞性肠炎,14只犬(82%)有淋巴管扩张,10只犬(59%)有嗜酸性粒细胞浸润。11只犬(65%)因肠道疾病实施安乐死或死亡。Kaplan-Meier分析显示中位生存时间为5个月,1年生存率为47%。7只犬(4%)经免疫抑制剂和饮食措施治疗后疾病缓解,但部分复发(中位无病间隔21个月)。
对于出现慢性腹泻和体重减轻的罗威纳犬,临床医生应考虑存在严重PLE,其预后较差。